Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Goodfellow

Showing results (361-370 of 382) with videos related to

Pageof 39
Sort By:
Gynecologic Oncology|March 19, 2017
FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group studyYvette W Jeske, Shamshad Ali, Sara A Byron, et al.
Journal of the National Cancer Institute|November 21, 2017
MAX Mutations in Endometrial Cancer: Clinicopathologic Associations and Recurrent MAX p.His28Arg Functional CharacterizationChristopher J Walker, Craig M Rush, Paola Dama, et al.
Nucleic Acids Research|January 9, 2016
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrenceBenjamin Sunkel, Dayong Wu, Zhong Chen, et al.
Nucleic Acids Research|April 19, 2017
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrenceBenjamin Sunkel, Dayong Wu, Zhong Chen, et al.
Gynecologic Oncology|July 16, 2017
Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survivalCasey M Cosgrove, David E Cohn, Heather Hampel, et al.
Cancer|May 10, 2017
Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencingMatthieu Le Gallo, Meghan L Rudd, Mary Ellen Urick, et al.
The Journal of Molecular Diagnostics : JMD|June 5, 2012
ColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencingColin C Pritchard, Christina Smith, Stephen J Salipante, et al.
The Journal of Pathology|June 2, 2012
Use of mutation profiles to refine the classification of endometrial carcinomasMelissa K McConechy, Jiarui Ding, Maggie Cu Cheang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2016
Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group StudyD Scott McMeekin, David L Tritchler, David E Cohn, et al.
Gynecologic Oncology|March 5, 2019
GOG 8020/210: Risk stratification of lymph node metastasis, disease progression and survival using single nucleotide polymorphisms in endometrial cancer: An NRG oncology/gynecologic oncology group studyRebecca A Brooks, David S Tritchler, Kathleen M Darcy, et al.
Pageof 39

Showing results (361-370 of 382) with videos related to

Sort By:
Pageof 39
Gynecologic Oncology|March 19, 2017
FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group studyYvette W Jeske, Shamshad Ali, Sara A Byron, et al.
Journal of the National Cancer Institute|November 21, 2017
MAX Mutations in Endometrial Cancer: Clinicopathologic Associations and Recurrent MAX p.His28Arg Functional CharacterizationChristopher J Walker, Craig M Rush, Paola Dama, et al.
Nucleic Acids Research|January 9, 2016
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrenceBenjamin Sunkel, Dayong Wu, Zhong Chen, et al.
Nucleic Acids Research|April 19, 2017
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrenceBenjamin Sunkel, Dayong Wu, Zhong Chen, et al.
Gynecologic Oncology|July 16, 2017
Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survivalCasey M Cosgrove, David E Cohn, Heather Hampel, et al.
Cancer|May 10, 2017
Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencingMatthieu Le Gallo, Meghan L Rudd, Mary Ellen Urick, et al.
The Journal of Molecular Diagnostics : JMD|June 5, 2012
ColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencingColin C Pritchard, Christina Smith, Stephen J Salipante, et al.
The Journal of Pathology|June 2, 2012
Use of mutation profiles to refine the classification of endometrial carcinomasMelissa K McConechy, Jiarui Ding, Maggie Cu Cheang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2016
Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group StudyD Scott McMeekin, David L Tritchler, David E Cohn, et al.
Gynecologic Oncology|March 5, 2019
GOG 8020/210: Risk stratification of lymph node metastasis, disease progression and survival using single nucleotide polymorphisms in endometrial cancer: An NRG oncology/gynecologic oncology group studyRebecca A Brooks, David S Tritchler, Kathleen M Darcy, et al.
Pageof 39